Sathornsumetee, S., Desjardins, A., Vredenburgh, J. J., McLendon, R. E., Marcello, J., Herndon, J. E., . . . Reardon, D. A. (2010). Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma. Oxford University Press.
Chicago Style CitationSathornsumetee, Sith, et al. Phase II Trial of Bevacizumab and Erlotinib in Patients With Recurrent Malignant Glioma. Oxford University Press, 2010.
Cita MLASathornsumetee, Sith, et al. Phase II Trial of Bevacizumab and Erlotinib in Patients With Recurrent Malignant Glioma. Oxford University Press, 2010.
Atenció: Aquestes cites poden no estar 100% correctes.